BACKGROUND: Skeletal muscle dysfunction is a common feature in chronic obstructive pulmonary disease (COPD) which is associated with intrinsic muscular abnormalities. One of the most consistently reported alterations is a shift from fibre type I to II in the vastus lateralis of these patients. Surprisingly, the relationship between this shift and the severity and phenotype of COPD remains unclear. A study was conducted to determine whether vastus lateralis muscle fibre type proportions are associated with COPD disease severity and to provide reference values for the proportions of fibre types in the vastus lateralis in COPD. METHODS: A systematic review and a meta-analysis were conducted in which muscle fibre type data and markers of disease severity were collected from the literature. RESULTS: The forced expiratory volume in 1 s (FEV(1)), the ratio of FEV(1) to forced vital capacity (FVC) and body mass index were positively associated with the proportion of type I fibres in COPD. A proportion of 51% for vastus lateralis fibre type I and 13% for fibre type IIX were calculated from the combined data as normal values for patients with typical GOLD stage 3-4 COPD aged 60-70 years. Based on these reference values, a proportion of fibre type I <27% and of fibre type IIX >29% were defined as pathologically abnormal. CONCLUSIONS: This review sheds new light on the relationship between skeletal muscle abnormalities and important hallmarks of the disease in severe COPD, and identifies absence of data in GOLD stages 1-2. This review also provides reference values on fibre type composition for diagnostic purposes in COPD.
BACKGROUND: Skeletal muscle dysfunction is a common feature in chronic obstructive pulmonary disease (COPD) which is associated with intrinsic muscular abnormalities. One of the most consistently reported alterations is a shift from fibre type I to II in the vastus lateralis of these patients. Surprisingly, the relationship between this shift and the severity and phenotype of COPD remains unclear. A study was conducted to determine whether vastus lateralis muscle fibre type proportions are associated with COPD disease severity and to provide reference values for the proportions of fibre types in the vastus lateralis in COPD. METHODS: A systematic review and a meta-analysis were conducted in which muscle fibre type data and markers of disease severity were collected from the literature. RESULTS: The forced expiratory volume in 1 s (FEV(1)), the ratio of FEV(1) to forced vital capacity (FVC) and body mass index were positively associated with the proportion of type I fibres in COPD. A proportion of 51% for vastus lateralis fibre type I and 13% for fibre type IIX were calculated from the combined data as normal values for patients with typical GOLD stage 3-4 COPD aged 60-70 years. Based on these reference values, a proportion of fibre type I <27% and of fibre type IIX >29% were defined as pathologically abnormal. CONCLUSIONS: This review sheds new light on the relationship between skeletal muscle abnormalities and important hallmarks of the disease in severe COPD, and identifies absence of data in GOLD stages 1-2. This review also provides reference values on fibre type composition for diagnostic purposes in COPD.
Authors: Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters Journal: Am J Clin Nutr Date: 2005-07 Impact factor: 7.045
Authors: Didier Saey; Annie Michaud; Annabelle Couillard; Claude H Côté; M Jeffery Mador; Pierre LeBlanc; Jean Jobin; François Maltais Journal: Am J Respir Crit Care Med Date: 2005-02-25 Impact factor: 21.405
Authors: Harry R Gosker; Patrick Schrauwen; Roelinka Broekhuizen; Matthijs K C Hesselink; Esther Moonen-Kornips; Kimberly A Ward; Frits M E Franssen; Emiel F M Wouters; Annemie M W J Schols Journal: Am J Physiol Endocrinol Metab Date: 2005-12-13 Impact factor: 4.310
Authors: M Doucet; R Debigaré; D R Joanisse; C Côté; P Leblanc; J Grégoire; J Deslauriers; R Vaillancourt; F Maltais Journal: Eur Respir J Date: 2004-12 Impact factor: 16.671
Authors: María Montes de Oca; Sonia H Torres; Yudith Gonzalez; Elizabeth Romero; Noelina Hernández; Abdón Mata; Carlos Tálamo Journal: Respir Med Date: 2006-03-20 Impact factor: 3.415
Authors: Bram van den Borst; Annemarie Koster; Binbing Yu; Harry R Gosker; Bernd Meibohm; Douglas C Bauer; Stephen B Kritchevsky; Yongmei Liu; Anne B Newman; Tamara B Harris; Annemie M W J Schols Journal: Thorax Date: 2011-07-01 Impact factor: 9.139
Authors: Diego de Paiva Azevedo; Wladimir Musetti Medeiros; Flávia Fernandes Manfredi de Freitas; Cesar Ferreira Amorim; Ana Cristina Oliveira Gimenes; Jose Alberto Neder; Luciana Dias Chiavegato Journal: Eur J Appl Physiol Date: 2016-07-28 Impact factor: 3.078
Authors: E B Swallow; E Barreiro; H Gosker; S A Sathyapala; F Sanchez; N S Hopkinson; J Moxham; A Schols; J Gea; M I Polkey Journal: Eur Respir J Date: 2009-05-14 Impact factor: 16.671
Authors: Howard J Green; Eric Bombardier; Margaret E Burnett; Christine L D'Arsigny; Sobia Iqbal; Katherine A Webb; Jing Ouyang; Denis E O'Donnell Journal: Int J Gen Med Date: 2009-12-29